Found 1151 clinical trials
An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)
An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)
- 168 views
- 08 Dec, 2020
- 1 location
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
- 68 views
- 08 Dec, 2020
- 1 location
An AI-based Method to Assess and Monitor the Cognitive Functions of Persons with Dementia
This pilot study will be investigating the feasibility of developing an AI solution to assess and monitor the progression of mild Alzheimer's dementia through automated speech and dialogue analysis. Using the Montreal Cognitive Assessment (MoCA) test, participants would be evaluated bi-monthly from August 2022 to April 2023 through in person …
- 20 views
- 22 Aug, 2022
- 1 location
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease
- 87 views
- 25 Mar, 2021
- 1 location
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
- 258 views
- 08 Dec, 2020
- 1 location
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery
- 92 views
- 25 Mar, 2021
- 1 location
Hyperbaric Oxygen (HBO) Therapy for Traumatic Brain Injury
Hyperbaric Oxygen (HBO) Therapy for Traumatic Brain Injury
- 4191 views
- 25 Mar, 2021
- 1 location
Aging Research Characterizing Health Equity via Social determinants (ARCHES)
Black Americans have more occurrences of chronic diseases, a higher rate of death, and are at twice the risk of Alzheimer’s disease (AD) compared to White Americans. However, these differences aren’t tied to the individual communities. They are tied to the conditions of the environment surrounding them (e.g., stress, discrimination, …
- 0 views
- 23 Jan, 2023
- 1 location
Alzheimer's Disease
As we age, brain changes can result in memory concerns. There are, however, some cognitive changes that are not part of the normal aging process, but may actually be the onset of Alzheimer’s disease. Alzheimer’s disease is a degenerative disorder that destroys nerve cells (neurons) in the brain. As these …
- 23 views
- 30 Jul, 2021
- 1 location
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
ADvance II: A 12-month Double-blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease
- 0 views
- 22 Nov, 2021
- 12 locations